Camlin Fine Sciences Management Meet Update - Execution Is The Key: Nirmal Bang

Camlin Fine Sciences Management Meet Update - Execution Is The Key: Nirmal Bang

<div class="paragraphs"><p>A scientist testing a solution in a lab. (Source: Unsplash)</p></div>
A scientist testing a solution in a lab. (Source: Unsplash)

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Nirmal Bang Report

We hosted the management of Camlin Fine Sciences Ltd. at our Annual Investor Conference in order to understand the overall demand outlook across segments, impact of the Russia-Ukraine conflict, if any, capex plans, effectiveness of pass-through mechanism under an inflationary environment and overall growth drivers.

Demand for anti oxidant blends continues to remain robust and Camlin Fine expects strong growth across geographies. HQEE, PBQ, MEHQ etc. are some of the products which should drive growth of the performance chemicals segment.

Vanillin capacity is expected to be commissioned in July 2022 and potential revenue could be ~Rs 5 billion at peak.

Click on the attachment to read the full report:

Nirmal Bang Camlin Fine Sciences-Management Meet Update-6 June 2022.pdf


This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.